GUANZE MEDICAL Reports Fiscal 2025 Loss Attributable to Shareholders of RMB29.72 Million

Stock News
03/31

GUANZE MEDICAL (02427) announced its annual results for the period ending December 31, 2025. Revenue amounted to RMB88.45 million, representing a decrease of 43.2% compared to the previous year. The loss attributable to the company's owners was RMB29.72 million, a significant shift from a profit of RMB17.20 million in the same period last year. The basic loss per share was RMB0.03. The decline in total annual revenue was primarily due to reduced sales of medical imaging film products and medical imaging cloud services.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10